ODOBGYNDECODED

← Clinical library

Obstetrics

PPROM (Preterm Prelabour Rupture of Membranes 24+0-36+6)

IN REVIEWv3🌍 International referencePENDING CLINICAL VERIFICATION
Confirm rupture, exclude labour/infection, then EXPECTANCY with latency antibiotics (erythromycin 250 mg QDS x10 days per GTG73), steroids, surveillance for chorioamnionitis; deliver ~34 wks (individualise 30-36+6).

Admission & discharge ↓

Reviewer note: Medication regimens and dependent emergency instructions checked 17 October 2026. These targeted checks do not certify every statement in the module. Admission/discharge guidance checked 18 October 2026. This adds a scoped clinical synthesis and does not certify every statement in the module.

Clinical detail

Additional detail checked 2026-10-17 against the linked sources. This check covers the section below; the rest of the module retains its displayed verification status.

PPROM combines prematurity risk with infection, cord-prolapse and other obstetric risks. Decisions depend on both maternal and fetal condition, not only gestational age.

Assessment & interpretation

  • Assess the history of fluid loss and confirm rupture through the appropriate examination and testing.
  • Record maternal observations, fetal condition, pain, bleeding, fluid appearance and signs of infection.

Decisions that change management

  • Discuss antibiotics, antenatal corticosteroids, neonatal care and the plan for timing of birth with the obstetric team.
  • When mother and fetus remain well, expectant care may be appropriate. Infection or another complication can require earlier delivery; treatment to prolong pregnancy must not override deterioration.

Follow-up & safety-netting

  • Give explicit return advice for fever or feeling unwell, abdominal pain, offensive fluid, bleeding, contractions or reduced movements.
  • If outpatient monitoring is selected, document the surveillance schedule and access to urgent review.
  • After birth, explain the event and assess the implications for a future pregnancy.

Clinical pitfalls

  • A reassuring earlier assessment does not exclude infection later. A change in symptoms needs a new clinical assessment.
Sources for this detail:

Admission & discharge

Care setting: Initial hospital observation; selected stable patients may later receive home surveillance

Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.

When admission or continued hospital care is needed

  • Admit suspected infection, labour, bleeding, fetal compromise, maternal illness or inability to attend monitoring/return rapidly.

When clinic, day care or home care may be suitable

  • RCOG describes hospital observation for a few days after PPROM, followed by individual consideration of home care if mother and baby are well and early-birth risk/access arrangements allow it.

Before going home

  • No infection/labour/bleeding or maternal/fetal concern needing inpatient care; a senior team has agreed surveillance, transport and timing/place of birth.
  • Counselling includes that complications can arise after leaving and a previously reassuring review does not guarantee continued safety.

Discharge medicines and treatment changes

  • Complete only the remaining portion of the prescribed latency antibiotic course, with the original start/stop dates. Record completed/remaining steroid doses; do not restart a full course because of discharge.
Medicine doses — use only when indicated

Use the medicines selected for this patient. Listed alternatives are not instructions to prescribe all of them together. Confirm the actual remaining course, pregnancy/postnatal context and monitoring plan.

Only the remaining prescribed latency course; confirm the course has not already finished.

Erythromycin — PPROM latencyNICE · NG25checked
Dose250 mg
RouteOral
FrequencyFour times daily
DurationMaximum 10 days OR until established labour, whichever occurs first (NICE NG25)
Preparation250 mg tablets; confirm the erythromycin salt and avoid erythromycin estolate in pregnancy. Do not substitute co-amoxiclav for latency prophylaxis
Max dose1 g/day for at most 10 days in this regimen
  • Indication: Confirmed PPROM without established infection or another indication for immediate birth
Monitoring
  • Temperature, pulse, uterine tenderness, fetal status and drug tolerance; infection changes management
Contraindications: Macrolide allergy; QT prolongation and interacting drugs; do not use latency antibiotics to defer delivery in sepsis

Tests, pending results and their reviewer

  • Document fetal surveillance, growth/other planned scans and clinical/laboratory infection assessment. No single normal inflammatory marker rules out infection.

Home care and counselling

  • Give the unit contact, monitoring appointments and advice about temperature, colour/smell of fluid, pain, contractions and fetal movement.

Follow-up: when and what to review

WhenAction / responsible service
At the exact scheduled maternity checks
Review maternal symptoms/observations and fetal wellbeing; reassess admission/birth if concerns emerge.
At the agreed gestation or earlier complication
Confirm the individual birth plan and neonatal arrangements.

Return urgently

  • Fever/shivering, offensive or changing fluid, abdominal/back pain, contractions, bleeding or reduced movements: return immediately.

Open the complete discharge checklist →

Treatment

① Immediate stabilization — first minutes
  • Admit initially; no digital PV exams
  • Anti-D for Rh-negative women
③ First-line treatment & drug regimens
Erythromycin — PPROM latencyNICE · NG25checked
Dose250 mg
RouteOral
FrequencyFour times daily
DurationMaximum 10 days OR until established labour, whichever occurs first (NICE NG25)
Preparation250 mg tablets; confirm the erythromycin salt and avoid erythromycin estolate in pregnancy. Do not substitute co-amoxiclav for latency prophylaxis
Max dose1 g/day for at most 10 days in this regimen
  • Confirmed PPROM without established infection or another indication for immediate birth
Monitoring
  • Temperature, pulse, uterine tenderness, fetal status and drug tolerance; infection changes management
Contraindications: Macrolide allergy; QT prolongation and interacting drugs; do not use latency antibiotics to defer delivery in sepsis
Betamethasone — antenatal courseWHOsummary checked
Dose12 mg IM, then 12 mg IM 24 hours later
RouteIM
FrequencyTwo doses, 24 h apart
DurationOne 24 mg course. Consider only ONE repeat course under NICE criteria; not routine weekly courses
PreparationConfirm product strength: for 6 mg/mL, 12 mg = 2 mL; volumes differ by formulation. Use the obstetric IM preparation
Max dose24 mg/course; NICE permits no more than 2 courses in total under its repeat-course criteria
  • Imminent preterm birth within the guideline gestational window; do not delay urgent maternal/fetal delivery
  • NICE offers at 24+0–33+6 weeks, considers 34+0–35+6; individual discussion at 22+0–23+6. Repeat: <34 weeks, prior course >7 days ago and very high risk of birth in 48 h.
Monitoring
  • Glucose monitoring and an insulin-adjustment plan in diabetes; assess infection and timing of birth
Contraindications: Do not delay lifesaving delivery to complete steroids; do not use a blanket “infection contraindication” without senior assessment
  • EXPECTANT management if no labour/infection and mother stable
  • Planned birth around 34 wks (individualise earlier with infection/growth issues; some units extend 34-36+6 for favourable late cases)
④ Drug treatment detail (2 agents)
Dexamethasone — antenatal alternativeWHOsummary checked
Dose6 mg IM every 12 h for four doses
RouteIM
FrequencyEvery 12 hours, four doses
Duration24 mg total over 36 h; ONE course, subject to the same repeat-course restrictions
PreparationCheck the injectable product: if 4 mg/mL, 6 mg = 1.5 mL; other strengths require recalculation. Give IM for this antenatal regimen
Max doseFour 6 mg doses = 24 mg/course; do not combine with a full betamethasone course
  • Indication: Alternative fetal-lung-maturation course when appropriate
Monitoring
  • Maternal glucose, infection assessment and birth timing; diabetes team plan
Contraindications: Do not prolong an unsafe pregnancy to finish the course
Magnesium sulfate — fetal neuroprotectionNICE · NG25checked
Dose4 g over 15 min, then 1 g/hour
RouteIV infusion
FrequencyLoading once, then continuous infusion
DurationStop at birth or 24 hours, whichever occurs first
Preparation50%: 4 g = 8 mL diluted in compatible sodium chloride 0.9%; maintenance example 20 g made up to FINAL 100 mL, 5 mL/hour via pump
Max dose24 hours for neuroprotection; do not add to an eclampsia regimen already running
  • Indication: Imminent preterm birth: NICE offers at 24+0–29+6 weeks and considers at 30+0–33+6 weeks; discuss 23+0–23+6 individually
Monitoring
  • Record pulse, BP, respiratory rate and tendon reflexes at least every 4 h; more often if oliguria or renal impairment
Contraindications: Myasthenia gravis, heart block or magnesium toxicity · Renal impairment or oliguria requires reduced/withheld maintenance and more frequent assessment
Definitive treatment

Birth on reaching threshold gestation or ANY red-flag trigger.

Monitoring
Latency scheduleFrequency
Temperature/pulse
4-6 hourly (fever >37.8 = review now)
CTG
Daily from viability thresholds per unit policy
CBC/CRP
Twice weekly minimum
Liquor/presentation US
Weekly
Fetal growth/Doppler
Every 2 weeks
Response assessment
  • Afebrile latency with stable labs; pregnancy advances toward target
Treatment failure
  • Any infection sign -> antibiotics (broaden: ampicillin+gentamicin+metronidazole IV) + birth
  • Labour onset -> established-PTL pathway additions
Escalation
  • Transfer to NICU-centre once stable if local nursery limited
  • Previable (<24 wks) rupture: specialist counselling pathway - expectancy vs termination options, infection/limb-defect risks discussed honestly
⑮ Complications & their management
Chorioamnionitis

Triple antibiotics + birth; placental histology; neonatal sepsis workup alert

Cord prolapse

Emergency module

Abruption

Abruption pathway

Pulmonary hypoplasia (very early rupture)

Counselled at previable/early-second-trimester ruptures; neonatal expectations set

Post-treatment care
  • Post-birth: placenta histology, neonatal cultures coordination
  • Subsequent-pregnancy advice: progesterone considerations, serial cervix surveillance

Diagnosis & assessment

Red flags:
  • Chorioamnionitis (fever, maternal/fetal tachycardia, foul liquor, uterine tenderness) -> antibiotics + DELIVER
  • Abrupt placental separation signs
  • Cord prolapse (check every presentation)
  • Non-reassuring CTG

Definition: Spontaneous membrane rupture before labour onset between 24+0 and 36+6 weeks.

Initial assessment

  1. History + speculum pooling (avoid digital exams!); confirm rupture (IGFBP-1/PLGA swabs where equivocal)
  2. TVS presentation check; cord location
  3. CTG; CBC/CRP baseline
  4. GBS status noted
  5. Viability/dating confirmation

Investigations

TestLooking for
Speculum + confirmatory tests
Diagnosis without digital examination
Serial CBC/CRP + temp chart
Latency infection surveillance

Principles & follow-up

Management principles

Sources (10)

RCOG — Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation (Green-top Guideline No. 73)
2019-06-18 · checked 2026-08-23 · verified-live
Open source ↗

RCOG page incl. June 2022 update note aligning steroids advice with GTG 74 (offer up to 33+6; consider to 35+6 with caution per GTG74 Feb 2022)

RCOG — Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality (Green-top Guideline No. 74)
2022-02 · checked 2026-08-23 · pending-verification
Open source ↗

Cited via RCOG GTG73 update note; direct PDF audit pending — flag

RCOG — When your waters break prematurely — patient information
· checked 2026-10-18 · verified-live
Open source ↗

Scope: additional clinical-detail explanation for pprom. Checked the assessment, management-decision and follow-up statements in that section against this source. This does not certify all pre-existing regimens, calculations or recommendations in the module. Additional admission/discharge check 18 O…

NICE — NG25 — preterm labour and birth
20 November 2015 · updated 10 June 2022 · checked 2026-10-18 · verified-live
Open source ↗

Scope: additional clinical-detail explanation for ptl-threatened, ptl-established. Checked the assessment, management-decision and follow-up statements in that section against this source. This does not certify all pre-existing regimens, calculations or recommendations in the module. Additional admi…

WHO — Antenatal corticosteroids for improving preterm birth outcomes — 2022
· checked 2026-10-17 · verified-summary
Open source ↗

Recommendation 1.9/type-and-regimen evidence: IM dexamethasone or betamethasone total 24 mg; four 6 mg dexamethasone doses 12 hours apart or two 12 mg betamethasone doses 24 hours apart. NICE NG25 supplies gestational and repeat-course criteria.

NICE — Postnatal care — NG194
· checked 2026-10-18 · verified-live
Open source ↗

Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.

India MoHFW / NHM — District Hospital Standard Operating Procedures — LaQshya
· checked 2026-10-18 · verified-live
Open source ↗

Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.

WHO — WHO recommendations on quality postnatal care — official recommendation summary
· checked 2026-10-18 · verified-live
Open source ↗

Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.

RCOG — Laparoscopy — recovering well
· checked 2026-10-18 · verified-live
Open source ↗

Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…

NICE — Acutely ill adults in hospital — CG50
· checked 2026-10-18 · verified-live
Open source ↗

Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.